Dr. Thomas Pedicino Kole, MD, PhD
- Medicare services, 2024
- 2,278
- Medicare patients, 2024
- 293
- Part D claims, 2024
- 545
- Publications
- 21
- Clinical trials
- 2
- Practice address
- 1275 York Avenue, New York, NY 10065
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Kole's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Thomas Pedicino Kole is a radiation oncologist in New York, New York
Dr. Kole practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.
Dr. Kole's NPI, 1598064545, was assigned on March 16, 2011. Dr. Kole graduated from Rutgers New Jersey Medical School in 2010. Dr. Kole holds New Jersey license 25MA09778100.
- NPI
- 1598064545NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4789995556
- NPI enumeration date
- March 16, 2011
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 42
- Medical school graduation
- 2010
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Thomas Pedicino Kole practices at Memorial Sloan Kettering Cancer Center in New York, New York
Dr. Kole's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.
- Memorial Sloan Kettering Cancer Center1275 York Avenue, New York, NY 10065
Source: Dmand AI Affiliation Data
Dr. Thomas Pedicino Kole is affiliated with 5 sites of care and 5 medical groups
Dr. Kole's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Valley Medical Group. Dmand AI also links Dr. Kole to 4 more group practices and clinics and 4 medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Thomas Pedicino Kole's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kole practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Memorial Sloan Kettering Cancer Center | Available with a free account |
| +4 more sites and 4 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Thomas Pedicino Kole is one of 385 radiation oncologists in New York
Radiation oncology is Dr. Kole's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Kole is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Kole's licenses on file in 4 states: New Jersey, Florida, New York and District of Columbia.
Specialties and state licenses
- Radiation oncology, New JerseyPrimary
- Florida license
- New York license
- District of Columbia license
Clinical focus
Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation, pancreatic cancer radiation and prostate cancer radiation among the conditions Dr. Kole treats.
Radiation oncologists near Dr. Kole
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Thomas Pedicino Kole billed Medicare for 2,278 services in 2024
CMS data shows 2,278 Medicare services from Dr. Kole across 19 procedure codes in 2024, for 293 Medicare patients. Medicare paid $228,016 for them.
Dr. Kole's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Imaging
- 2023: 2,0672024: 1,73416%
- Other services
- 2023: 1122024: 22298%
- Office and hospital visits
- 2023: 2512024: 18227%
- Surgery
- 2023: 1252024: 14012%
Where Dr. Kole's Medicare services took place, 2024
- In an office62728%
- In a facility1,65172%
Dr. Kole compared with the New York median for radiation oncologists, 2024
- Dr. Kole
- New York median
- Medicare services
- 2,278vs 1,0542.2 times
- Medicare patients
- 293vs 16083% above
- Part D claims
- 468vs 3613.0 times
Medians across 368 radiation oncologists in New York with Dmand AI profiles that report each measure.
Dr. Kole's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kole?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kole and other radiation oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Thomas Pedicino Kole treated 293 Medicare patients in 2024, average age 75
CMS counts 293 Medicare patients who saw Dr. Kole in 2024. The largest group is 65 to 74, with 146 patients. 75% of them have cancer, and 75% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Kole's median patient age at 72, with 7% women.
Dr. Kole's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Kole's Medicare patients by sex, 2024
- Women9031%
- Men20369%
Chronic conditions among Dr. Kole's Medicare patients, 2024
- Cancer75%
- High blood pressure75%
- High cholesterol75%
- Arthritis43%
- Ischemic heart disease35%
- Diabetes29%
- Anxiety28%
- Chronic kidney disease20%
Share of Medicare patients with each condition. A patient can have several.
Dr. Kole's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women7%
- Men92%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Thomas Pedicino Kole wrote 545 Medicare Part D claims in 2024
In 2024, Dr. Kole wrote 545 Medicare Part D claims for 166 patients. 97% of them were for generic drugs. CMS names the drug for 468 of them, across 4 drugs with 11 or more claims each, at $5,257 in total drug cost. In 2023, CMS named 449 claims across 3 drugs.
Dr. Kole's Part D claims by kind of drug, 2024
- Generic529 claims97%
- Brand-name16 claims3%
Dr. Kole's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Kole's Part D claims, 2024
- Antibiotics14%77 of 545 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 4492024: 4684%
Drugs named by CMS: 4 in 2024, 3 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Thomas Pedicino Kole scored 95 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Kole for performance year 2024, reported through an alternative payment model (APM). Dr. Kole accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kole as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Kole's MIPS scores, performance year 2024
- 95of 100Final score
- 85.7of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Thomas Pedicino Kole has 21 publications on record
Dmand AI links 21 papers to Dr. Kole, published from 2013 to 2023. 2015 was the busiest year, with 5. The most frequent topics are Radiosurgery, Prostatic Neoplasms and Urinary Bladder. Dr. Kole has published most often in Acta Oncol. Dr. Kole's most frequent co-authors are Brian Collins, John Hugh Lynch, MD and Olusola Obayomi-Davies, MD.
Dr. Kole's papers by year, 2013 to 2023
Topics Dr. Kole writes about most
- Radiosurgery
- Prostatic Neoplasms
- Urinary Bladder
- Organs at Risk
- Organ Size
- Rectum
Dr. Kole's most frequent co-authors
- Brian Collins5 shared papers
- John Hugh Lynch, MD4 shared papers
- Olusola Obayomi-Davies, MD4 shared papers
Recent publications by Dr. Kole
See who Dr. Kole researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kole works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Thomas Pedicino Kole has worked on 2 clinical trials
Dmand AI links Dr. Kole to 2 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. NRG Oncology sponsors the most, 2.
Conditions in Dr. Kole's trials
- Prostatic Neoplasms
- Prostatic Diseases
Investigators on the most trials with Dr. Kole
- Alan C. Hartford, MD, PhD2 shared trials
- Ashesh B. Jani, MD2 shared trials
- Bryan James Traughber, MD2 shared trials
Recent clinical trials with Dr. Kole
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial (opens in a new tab)
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Thomas Pedicino Kole received $9,088 in industry payments from 2016 to 2025
CMS Open Payments shows 94 general payments to Dr. Kole from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 47% of the total. Brainlab, Inc. paid the most, $4,773.
General payments to Dr. Kole by program year, 2016 to 2025
General payments to Dr. Kole by kind, 2016 to 2025
- Food and beverage$4,26447%
- Travel and lodging$2,32426%
- Consulting fees$1,50017%
- Honoraria$1,00011%
Companies that paid Dr. Kole the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Thomas Pedicino Kole has 2 awards and honors on record
Dmand AI lists 2 awards for Dr. Kole, most recently Stanley Bergen Medal of Excellence in 2010.
Awards and honors for Dr. Kole
- 2010
- Stanley Bergen Medal of Excellence
- 2009
- Member
Source: Dmand AI Professional Profile Data
Dr. Thomas Pedicino Kole graduated from Rutgers New Jersey Medical School
Dr. Kole graduated from Rutgers New Jersey Medical School in 2010. Dr. Kole is a member of AOA and ASTRO.
- Medical school
- Board certified in radiation oncology
Source: Dmand AI Professional Profile Data
Dr. Thomas Pedicino Kole accepts plans from 15 insurance carriers
Dr. Kole is in network with 15 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.
- Elevance
- Aetna
- United Healthcare
- HCSC
- Horizon Blue Cross Blue Shield of New Jersey
- Aspirus Health Plan
- Blue Cross Blue Shield of Massachusetts
- Blue Cross Blue Shield of Michigan
- +7 more carriersWith a free account
Plan types Dr. Kole accepts, by number of carriers
- Medicare11
- PPO11
- HMO6
- EPO4
- POS4
- Medicaid2
Source: Dmand AI Insurance Network Data
Sources for Dr. Thomas Pedicino Kole's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Thomas Pedicino Kole
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Thomas Pedicino Kole's NPI number?
Dr. Thomas Pedicino Kole's NPI number is 1598064545. It was assigned on March 16, 2011, and it is active in the NPI Registry.
What kind of doctor is Dr. Thomas Pedicino Kole?
Dr. Thomas Pedicino Kole is a radiation oncologist in New York, New York. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. Thomas Pedicino Kole practice?
Dr. Kole practices at 1275 York Avenue, New York, NY 10065. Dr. Kole's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Kole to 4 group practices and clinics and 4 medical groups.
What is Dr. Thomas Pedicino Kole's medical license number?
Dr. Kole holds New Jersey license 25MA09778100, one of the licenses on file in 4 states.
Which states has Dr. Thomas Pedicino Kole been licensed in?
Dmand AI has state licenses on file for Dr. Kole in New Jersey (2015 to 2027), Florida (since 2025), New York (2015 to 2026) and District of Columbia (2011 to 2012).
Which hospitals is Dr. Thomas Pedicino Kole affiliated with?
Dr. Kole practices at Memorial Sloan Kettering Cancer Center in New York, New York.
What medical group is Dr. Thomas Pedicino Kole part of?
Dr. Kole is linked to Valley Medical Group. Dmand AI links Dr. Kole to 4 more medical groups.
Does Dr. Thomas Pedicino Kole accept Medicare?
Yes. CMS data shows Dr. Kole billed Medicare for 2,278 services in 2024, and Dr. Kole accepts Medicare assignment.
Does Dr. Thomas Pedicino Kole offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Kole as offering telehealth services.
What is Dr. Thomas Pedicino Kole's MIPS score?
Dr. Kole's MIPS final score for performance year 2024 is 95 out of 100, reported through an alternative payment model (APM).
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Thomas Pedicino Kole see?
CMS counts 293 Medicare patients who saw Dr. Kole in 2024, with an average age of 75.
Is Dr. Thomas Pedicino Kole board certified?
Yes. Dr. Kole is board certified in radiation oncology by the American Board of Radiology.
What services does Dr. Thomas Pedicino Kole bill to Medicare?
In 2024, Dr. Kole's most billed Medicare services were radiation oncology (77014), radiation oncology (77300) and radiation oncology (77427).
Where did Dr. Thomas Pedicino Kole go to medical school?
Dr. Kole graduated from Rutgers New Jersey Medical School in 2010.
What drugs does Dr. Thomas Pedicino Kole prescribe most?
In 2024 Medicare Part D data, Dr. Kole's most prescribed drugs by claims were Tamsulosin HCl, Dexamethasone and Sulfamethoxazole-Trimethoprim.
Has Dr. Thomas Pedicino Kole received payments from drug or device companies?
CMS Open Payments shows $9,088 in general payments to Dr. Kole from 24 companies from 2016 to 2025. The largest total came from Brainlab, Inc.
How long has Dr. Thomas Pedicino Kole been practicing?
Dr. Kole graduated from medical school in 2010, 16 years ago.
Does Dr. Thomas Pedicino Kole do research?
Dmand AI links 21 publications to Dr. Kole, published from 2013 to 2023. Dr. Kole has worked on 2 clinical trials.
Who does Dr. Thomas Pedicino Kole publish with?
Dr. Kole's most frequent co-authors are Brian Collins (5 shared papers), John Hugh Lynch, MD (4 shared papers) and Olusola Obayomi-Davies, MD (4 shared papers).
What insurance does Dr. Thomas Pedicino Kole accept?
Dr. Kole is in network with 15 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.
Selling to radiation oncology practices?
See radiation oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card